Twist Bioscience Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Twist Bioscience stock has a consensus rating of "Strong Buy" and an average price target of $64.38. The average 1-year stock price forecast is 15.48% lower than the current stock price, while the lowest is $36 (-52.74%) and the highest is $80 (+5.03%).

Price Target: $64.38 (-15.48%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$36	$64.38	$65.5	$80
Change	-52.74%	-15.48%	-14.01%	+5.03%

Analyst Ratings

The average analyst rating for Twist Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	7	7	7	7	8	7
Buy	1	1	1	1	1	1
Hold	2	2	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	10	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Westenberg Piper Sandler	Piper Sandler	Buy Initiates $85	Buy	Initiates	$85	+11.59%	Jun 11, 2026
Matt Larew William Blair	William Blair	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	May 26, 2026
Luke Sergott Barclays	Barclays	Buy Maintains $65	Buy	Maintains	$65	-14.66%	May 26, 2026
Brendan Smith TD Cowen	TD Cowen	Buy Reiterates $68	Buy	Reiterates	$68	-10.73%	May 22, 2026
Subbu Nambi Guggenheim	Guggenheim	Buy Maintains $60	Buy	Maintains	$60	-21.23%	May 22, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

446.59M

from 376.57M

18.59%

from 376.57M

Revenue Next Year

516.95M

from 446.59M

15.76%

from 446.59M

EPS This Year

-0.58

from -2.12

EPS Next Year

-0.97

from -0.58

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026
Revenue	132.33M	203.57M	245.11M	312.97M	376.57M	446.59M
Revenue Growth	46.87%	53.83%	20.41%	27.69%	20.32%	18.59%
Gross Profit	51.71M	84.24M	89.73M	133.35M	191.00M	233.25M
Gross Margin	39.08%	41.38%	36.61%	42.61%	50.72%	52.23%
Operating Income	-153.26M	-249.02M	-206.90M	-175.90M	-136.26M	-136.03M
Net Income	-152.10M	-217.86M	-204.62M	-208.73M	-77.67M	-128.57M
EPS	-	-	-	-	-2.12	-0.58
Free Cash Flow	-73.09M	-160.52M	-112.43M	-17.42M	-32.63M	17.00M
No. Analysts	-	-	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	447.0M
Avg	446.6M
Low	446.1M

Revenue Growth

Revenue Growth	2026	2027	2028
High	18.7%
Avg	18.6%
Low	18.5%

EPS Forecast

EPS	2026	2027	2028
High	-0.58
Avg	-0.58
Low	-0.58

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-